🇬🇧 AI-based digital twin tool to personalize diabetes care, therapeutic education, and enhance the patient experience.
Nov 22, 2023 — 03:05 pm CET - 3:15 PM CET
Hillo is pioneering AI-driven decision-support tools for diabetes patients and their care teams. Their digital twin technology, learning from real-life patient data, replicates patients' physiological responses. This enables an understanding of how therapeutic habits and patient behavior impact the disease, guiding treatment adjustments to reach targets recommended by care teams. In collaboration with Sanofi, Hillo is co-developing a platform that utilizes its technology to provide care teams with a new and unprecedented tool for personalizing diabetes care and enhancing the patient experience. Pilot studies are currently underway in major centers in France.